loadpatents
name:-0.0051398277282715
name:-0.014636993408203
name:-0.0016379356384277
Schickaneder; Helmut Patent Filings

Schickaneder; Helmut

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schickaneder; Helmut.The latest application filed is for "bendamustine derivatives and related compounds, and medical use thereof in cancer therapy".

Company Profile
2.16.8
  • Schickaneder; Helmut - Eckental DE
  • Schickaneder; Helmut - Cork IE
  • Schickaneder; Helmut - Poing DE
  • Schickaneder; Helmut - Eckental-Eckenhaid DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy
Grant 10,526,290 - Schickaneder , et al. J
2020-01-07
Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy
Grant 10,294,208 - Schickaneder , et al.
2019-05-21
Bendamustine Derivatives and Related Compounds, and Medical Use Thereof in Cancer Therapy
App 20170313663 - SCHICKANEDER; Helmut ;   et al.
2017-11-02
Bendamustine Derivatives And Related Compounds, And Medical Use Thereof In Cancer Therapy
App 20150152066 - Schickaneder; Helmut ;   et al.
2015-06-04
Esters of bendamustine and related compounds, and medical use thereof
Grant 8,809,549 - Schickaneder , et al. August 19, 2
2014-08-19
Esters Of Bendamustine And Related Compounds, And Medical Use Thereof
App 20130289032 - SCHICKANEDER; Helmut ;   et al.
2013-10-31
Process for the preparation of bendamustine hydrochloride and related compounds
App 20130184471 - Schickaneder; Helmut ;   et al.
2013-07-18
Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity
Grant 6,599,885 - Schickaneder , et al. July 29, 2
2003-07-29
Process for the preparation of Aceclofenac
App 20030060657 - Schickaneder, Helmut ;   et al.
2003-03-27
Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity
App 20010031736 - Schickaneder, Helmut ;   et al.
2001-10-18
Process for preparing form 1 ranitidine hydrochloride
Grant 5,663,381 - Schickaneder , et al. September 2, 1
1997-09-02
1,1,2-triphenylbut-1-ene derivatives
Grant 5,047,431 - Schickaneder , et al. September 10, 1
1991-09-10
Process for the preparation of 2,6-dichlorodiphenylaminoacetic acid derivatives
Grant 4,978,773 - Grafe , et al. December 18, 1
1990-12-18
Stable solvent adducts of Z-1-(p-.beta.-dimethylaminoethoxy-phenyl)-1-(p-hydroxyphenyl)-2-phenyl-b ut-1-ene
Grant 4,973,755 - Grafe , et al. November 27, 1
1990-11-27
Piperazine substituted 6-phenyldihydro-3(2H)-pyridazinones, and pharmaceutical preparations containing these
Grant 4,954,501 - Herter , et al. September 4, 1
1990-09-04
Dihydropyridazinone derivatives, a process for their preparation and pharmaceutical preparations containing these compounds
Grant 4,921,856 - Schickaneder , et al. May 1, 1
1990-05-01
Imidazoyl-substituted thiomethylpyridine derivatives, method of administration thereof and medicaments containing them
Grant 4,810,715 - Schickaneder , et al. March 7, 1
1989-03-07
Erythro-1,2-1-pentanones
Grant 4,764,533 - Schickaneder , et al. August 16, 1
1988-08-16
1,4-dihydropyridine derivatives
Grant 4,757,080 - Schickaneder , et al. July 12, 1
1988-07-12
Diamine derivatives and pharmaceutical preparations containing these compounds
Grant 4,656,180 - Postius , et al. April 7, 1
1987-04-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed